AOC3 and myocardial infarction: VAP-1 is upregulated in many human inflammatory diseases, such as acute myocardial infarction, inflammatory bowel disease and rheumatoid arthritis [45-48]; and a fully humanized anti-VAP-1 antibody is used in clinical trials for patients suffering from rheumatoid arthritis and psoriasis [49].